CD28 and cancer: Zou (87) showed that serum CD3+, CD4+, CD8+, and CD28+ T cells in older patients with lung cancer were significantly decreased compared with healthy older patients, and the CD28 mRNA content in peripheral blood of older patients with primary NSCLC was significantly lower than that in the healthy and non-cancer older groups.